ORGARAN
Google image searchProduct monograph
Active ingredient
danaparoid sodium, 750 UNIT/0.6 ML
DIN: 02129043
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: (1250 UNIT/ML)
Schedule: Prescription
Company: ASPEN PHARMACARE CANADA INC.
Date: 06-NOV-2018
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AB — Heparin group (ATC, ATC/DDD)
- B01AB09 — DANAPAROID (ATC/DDD)
Reference brand drug: Orgaran
